Cited by 32Pain Mechanisms and TreatmentsCannabis and Cannabinoid ResearchSpinal Cord Injury Research

Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain

Open access
Hama·2009·The Journal of Rehabilitation Research and Development

Abstract

A significant complaint associated with spinal cord injury (SCI) is chronic pain, which includes symptoms such as cutaneous hypersensitivity and spontaneous unevoked pain and is difficult to treat with currently available drugs. One complication with current analgesics is tolerance, a decrease in efficacy with repeated treatment over time. One promising class of pharmacological treatment is cannabinoid (CB) receptor agonists. The current study assessed the efficacy of the CB receptor agonist WIN 55,212-2 (WIN) in a rat model of neuropathic SCI pain. Brief spinal compression leads to significant hindpaw hypersensitivity to tactile stimulation. WIN dose-dependently increased withdrawal thresholds and continued to demonstrate efficacy over a twice-daily 7-day treatment regimen. By contrast, the efficacy of morphine in SCI rats decreased over the same treatment period. Similarly, the antinociceptive efficacy of WIN to acute noxious heat in uninjured rats diminished over time. These data suggest that the sustained efficacy of a CB receptor agonist for pain could depend on the pain state. Such agonists may hold promise for long-term use in alleviating chronic SCI pain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1682/jrrd.2008.04.0049

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chronic WIN55,212-2 reduced mechanical allodynia in the spinal cord injury model with no decrease in effectiveness over time, unlike morphine.

    “Unlike morphine, chronic administration of WIN55,212-2 reduced mechanical allodynia in the SCI model with no decrease in effectiveness over time.104”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [23]Tallarida RJ Murray RB Manual of pharmacological calculations with computer programs New York (NY) Springer-Verlag 1981 150

Cited by

Sorted by citations

Authors
Hama
Venue
The Journal of Rehabilitation Research and Development
Published
2009
Volume
46
Issue
1
Pages
135
ISSN
  • 0742-3241 (ISSN-L)
  • 0748-7711
OpenAlex
W2158497203
Cited by
32
References
52
Citations by year
2025: 1 · 2023: 3 · 2021: 5 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
1.77
Type
journal article
Language
en
Open access
Locations
  • The Journal of Rehabilitation Research and Development (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R21NS061172, NS61172)
Topics
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Spinal Cord Injury Research
Keywords
spinal cord injury, neuropathic pain, chronic pain, WIN 55,212-2, cannabinoid receptor agonists, analgesic tolerance, morphine, tactile hypersensitivity, antinociception, withdrawal threshold
MeSH terms
Analgesics, Opioid, Animals, Cannabinoids, Dose-Response Relationship, Drug, Hot Temperature, Male, Morphine, Morpholines, Naphthalenes, Neuralgia, Pain Measurement, Spinal Cord Injuries, Rats, Sprague-Dawley, Pain Threshold, Benzoxazines, Rats, Cannabinoid Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review